Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma-Reference-Cited by-同舟云学术

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Published:2020-05-06 Issue:12 Volume:26 Page:2827-2837
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Algazi Alain P.,Twitty Christopher G.,Tsai Katy K.,Le Mai,Pierce Robert,Browning Erica,Hermiz Reneta,Canton David A.,Bannavong Donna,Oglesby Arielle,Francisco Murray,Fong Lawrence,Pittet Mikael J.,Arlauckas Sean P.,Garris Christopher,Levine Lauren P.,Bifulco Carlos,Ballesteros-Merino Carmen,Bhatia Shailender,Gargosky Sharron,Andtbacka Robert H.I.,Fox Bernard A.,Rosenblum Michael D.,Daud Adil I.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-12 and PD-1 peptide combination gene therapy for the treatment of melanoma;Molecular Therapy - Nucleic Acids;2024-09

2. Intratumoral injection and retention hold promise to improve cytokine therapies for cancer;Frontiers in Oncology;2024-08-26

3. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

4. Tumor-Localized Interleukin-2 and Interleukin-12 Combine with Radiation Therapy to Safely Potentiate Regression of Advanced Malignant Melanoma in Pet Dogs;Clinical Cancer Research;2024-07-09

5. Review of Role of Surgery with Electroporation in Melanoma: Chemotherapy, Immunotherapy, and Gene Delivery;Journal of Clinical Medicine;2024-06-29